Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824

As a novel histone deacetylase inhibitor (HDACi), LAQ824 (LAQ) effectively inhibits the proliferation of hematological malignancies and solid tumors. However, phase II trials of LAQ in solid tumors were terminated due to dose-dependent toxicity. Furthermore, LAQ has been shown to induce the activati...

Full description

Bibliographic Details
Main Authors: Qinglang Mei, Xiaohan Xu, Danling Gao, Yuting Xu, Jinbo Yang
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/17/13660
_version_ 1797582335536791552
author Qinglang Mei
Xiaohan Xu
Danling Gao
Yuting Xu
Jinbo Yang
author_facet Qinglang Mei
Xiaohan Xu
Danling Gao
Yuting Xu
Jinbo Yang
author_sort Qinglang Mei
collection DOAJ
description As a novel histone deacetylase inhibitor (HDACi), LAQ824 (LAQ) effectively inhibits the proliferation of hematological malignancies and solid tumors. However, phase II trials of LAQ in solid tumors were terminated due to dose-dependent toxicity. Furthermore, LAQ has been shown to induce the activation of the Notch signaling pathway in hematopoietic stem cells, which is associated with tumor progression and drug resistance in colon and breast cancers. Therefore, in this study, we investigated the strategy of LAQ combined with a Notch signaling pathway inhibitor to treat solid tumors. We used RT-PCR and Western blot methods to demonstrate that LAQ upregulated the Notch signaling pathway in solid tumor cell lines at the molecular level. The combination of LAQ and a Notch signaling pathway inhibitor was shown by a Chou–Talalay assay to have a synergistic effect in inhibiting solid tumor cell line proliferation in vitro. We also demonstrated that the combination of LAQ and a Notch signaling pathway inhibitor significantly inhibited the growth of tumor cells in vivo using an allograft tumor model. This study indicates that inhibition of the Notch signaling pathway provides a valuable strategy for enhancing solid tumor sensitivity to LAQ.
first_indexed 2024-03-10T23:20:39Z
format Article
id doaj.art-914bcc004a0e49c8b5515448942fbba0
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T23:20:39Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-914bcc004a0e49c8b5515448942fbba02023-11-19T08:20:30ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-09-0124171366010.3390/ijms241713660Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824Qinglang Mei0Xiaohan Xu1Danling Gao2Yuting Xu3Jinbo Yang4Key Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, ChinaKey Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, ChinaKey Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, ChinaKey Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, ChinaKey Laboratory of Marine Drugs, Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, Qingdao 266003, ChinaAs a novel histone deacetylase inhibitor (HDACi), LAQ824 (LAQ) effectively inhibits the proliferation of hematological malignancies and solid tumors. However, phase II trials of LAQ in solid tumors were terminated due to dose-dependent toxicity. Furthermore, LAQ has been shown to induce the activation of the Notch signaling pathway in hematopoietic stem cells, which is associated with tumor progression and drug resistance in colon and breast cancers. Therefore, in this study, we investigated the strategy of LAQ combined with a Notch signaling pathway inhibitor to treat solid tumors. We used RT-PCR and Western blot methods to demonstrate that LAQ upregulated the Notch signaling pathway in solid tumor cell lines at the molecular level. The combination of LAQ and a Notch signaling pathway inhibitor was shown by a Chou–Talalay assay to have a synergistic effect in inhibiting solid tumor cell line proliferation in vitro. We also demonstrated that the combination of LAQ and a Notch signaling pathway inhibitor significantly inhibited the growth of tumor cells in vivo using an allograft tumor model. This study indicates that inhibition of the Notch signaling pathway provides a valuable strategy for enhancing solid tumor sensitivity to LAQ.https://www.mdpi.com/1422-0067/24/17/13660histone deacetylase inhibitorLAQ824Notch signaling pathwayPF03084014combination treatment
spellingShingle Qinglang Mei
Xiaohan Xu
Danling Gao
Yuting Xu
Jinbo Yang
Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
International Journal of Molecular Sciences
histone deacetylase inhibitor
LAQ824
Notch signaling pathway
PF03084014
combination treatment
title Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
title_full Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
title_fullStr Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
title_full_unstemmed Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
title_short Inhibition of Notch Signaling Enhances Antitumor Activity of Histone Deacetylase Inhibitor LAQ824
title_sort inhibition of notch signaling enhances antitumor activity of histone deacetylase inhibitor laq824
topic histone deacetylase inhibitor
LAQ824
Notch signaling pathway
PF03084014
combination treatment
url https://www.mdpi.com/1422-0067/24/17/13660
work_keys_str_mv AT qinglangmei inhibitionofnotchsignalingenhancesantitumoractivityofhistonedeacetylaseinhibitorlaq824
AT xiaohanxu inhibitionofnotchsignalingenhancesantitumoractivityofhistonedeacetylaseinhibitorlaq824
AT danlinggao inhibitionofnotchsignalingenhancesantitumoractivityofhistonedeacetylaseinhibitorlaq824
AT yutingxu inhibitionofnotchsignalingenhancesantitumoractivityofhistonedeacetylaseinhibitorlaq824
AT jinboyang inhibitionofnotchsignalingenhancesantitumoractivityofhistonedeacetylaseinhibitorlaq824